Skip to main content
. 2017 Jan 2;8(11):17887–17896. doi: 10.18632/oncotarget.14437

Figure 5. Fucoidan cooperates with specific inhibition of ERBB3.

Figure 5

A. Expression levels of ERBB3, phosphor-AKT in cells expressing a specific shERBB3 (left panel) and cells treated O/N with a specific ERBB3 neutralizing antibody (10 ug/ml) (right panel). B-C. % survival (evaluated by trypan blue count) of cells (WM266-4) expressing shERBB3 and treated for three days with fucoidan (1 mg/ml) (B) or treated with anti ERBB3 neutralizing antibody (10 ug/ml) and fucoidan (1 mg/ml) alone or in combination (C). P values were calculated by Student's t test.